These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 19832725
1. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin. Ray ER, Chatterton K, Khan MS, Chandra A, Thomas K, Dasgupta P, O'Brien TS. BJU Int; 2010 Mar; 105(6):789-94. PubMed ID: 19832725 [Abstract] [Full Text] [Related]
8. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ, PC B302/01 Study Group. J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283 [Abstract] [Full Text] [Related]
9. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, König F, Knüchel R, Kurth KH. J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971 [Abstract] [Full Text] [Related]
15. Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder. Lerner SP, Liu H, Wu MF, Thomas YK, Witjes JA. Urol Oncol; 2012 Aug; 30(3):285-9. PubMed ID: 21396840 [Abstract] [Full Text] [Related]
18. Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment. Kakiashvili DM, van Rhijn BW, Trottier G, Jewett MA, Fleshner NE, Finelli A, Azuero J, Bangma CH, Vajpeyi R, Alkhateeb S, Hanna S, Kostynsky A, Kuk C, Van Der Kwast TH, Zlotta AR. BJU Int; 2011 Feb; 107(4):540-6. PubMed ID: 21276177 [Abstract] [Full Text] [Related]
19. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. Andius P, Holmäng S. BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147 [Abstract] [Full Text] [Related]
20. A single-institution experience with induction and maintenance intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to bacille Calmette-Guérin therapy. Barlow L, McKiernan J, Sawczuk I, Benson M. BJU Int; 2009 Oct; 104(8):1098-102. PubMed ID: 19389012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]